Calgary‑based Cashee Research uses artificial intelligence to design and execute custom market‑research surveys, delivering fresh human data faster and at lower cost. The startup, founded by Addy Graves and Rose Wong, was selected for TechCrunch’s Startup Battlefield in 2025 and won the Enterprise Stage pitch at TechCrunch Disrupt. By combining AI‑generated survey plans with real‑world respondents, Cashee provides brands—especially small and medium‑size firms—with actionable insights that were previously too expensive or slow to obtain. The company has raised C$1.5 million in pre‑seed funding and is preparing a seed round to expand its U.S. presence and B2B business. Leia mais →

Nephrogen, a biotech startup founded by Stanford graduate Demetri Maxim, is developing an AI‑driven delivery system for gene‑editing medicines aimed at treating polycystic kidney disease (PKD). After a personal battle with PKD, Maxim combined insights from a 2021 Nature study with advanced screening to create a vehicle that is claimed to be 100 times more efficient than existing FDA‑approved options. The company, a finalist in TechCrunch Disrupt’s Startup Battlefield, is seeking a $4 million seed round to move its delivery platform and a companion drug into clinical trials, potentially as early as 2027. Leia mais →